Cytovale has developed a FDA-cleared, rapid diagnostic tool for sepsis, and it just raised $100 million to roll it out to hospital systems across the country. Every year, over 1.7 million Americans ...

A new blood test could quickly diagnose those at risk of sepsis and bring a 'paradigm shift' in treatment, according to early results from a clinical trial. The "low–cost" test takes just 45 minutes ...

During this webinar, we will provide an overview of the current landscape of sepsis management and the impact of rapid culture-independent diagnostics on healthcare systems. We will present the best ...

Every year some 49 million cases of sepsis occur, and 11 million sepsis-related deaths occurred worldwide in 2017, according to a study reported by the WHO. This accounts for 20% of all global deaths.

Qun Ren, an Empa researcher, and her team are currently developing a diagnostic procedure that can rapidly detect life-threatening blood poisoning caused by staphylococcus bacteria. Staphylococcal ...

Our immune systems can respond swiftly to an infection. But when the immune response is excessive or uncontrolled, it can cause a life-threatening condition known as sepsis. Any infection can lead to ...

Canadian scientists have developed a blood test and portable device that can determine the onset of sepsis faster and more accurately than existing methods. Published today in Nature Communications, ...

“Sepsis is more deadly than heart attack and stroke combined — in fact it’s the deadliest, costliest, and arguably most complex condition facing hospitals today.” IntelliSep was cleared by the FDA in ...

The immune system is generally a pro at fighting off microbial infections. But sometimes it goes rogue, turning itself on the body’s own organs and tissues, resulting in a life-threating condition ...

Boston — STMicroelectronics and Mobidiag (Helsinki, Finland) unveiled a DNA testing device at the Chips to Hits conference here last week aimed at detecting a variety of bacteria that cause septic ...

SIRS-Lab, the innovative molecular diagnostics company specialized in sepsis, today announced the successful completion of recruitment in its 1'000-patient trial. The prospective, blinded multicenter ...